Primary Site >> Pancreatic Cancer

Gene >> SLC44A4

Journal: JOP. 2013 Mar 10;14(2):138-40.
Title: Novel agents in the treatment of pancreatic adenocarcinoma.
Author: Dimou, Anastasios|Syrigos, Konstantinos N|Saif, Muhammad Wasif
PMID: 23474556
Journal: Invest New Drugs. 2016 Jun;34(3):319-28.
Title: A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers.
Author: Coveler, Andrew L|Ko, Andrew H|Catenacci, Daniel V T|Von Hoff, Daniel|Becerra, Carlos|Whiting, Nancy C|Yang, Jing|Wolpin, Brian
PMID: 26994014
Journal: Mol Cancer Ther. 2016 Nov;15(11):2679-2687.
Title: The Discovery and Preclinical Development of ASG-5ME, an Antibody-Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer.
Author: Mattie, Michael|Raitano, Arthur|Morrison, Kendall|Morrison, Karen|An, Zili|Capo, Linnette|Verlinsky, Alla|Leavitt, Monica|Ou, Jimmy|Nadell, Rossana|Avina, Hector|Guevara, Claudia|Malik, Faisal|Moser, Ruth|Duniho, Steven|Coleman, Jeffrey|Li, Ying|Pereira,
PMID: 27550944